Immune Checkpoint Inhibitors in Urothelial Bladder Carcinoma with Dr Joaquim Bellmunt
Dr Joaquim Bellmunt from the Beth Israel Deaconess Medical Center in Boston discusses the use of immune checkpoint inhibitors in urothelial bladder carcinoma. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayCheckpointInhibitionUBC20).
